Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats. 2004

Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
Medicinal Biology Research Laboratories, Fujisawa Pharmaceutical Co. Ltd, 2-1-6, Kashima, Osaka 532-8514, Japan. yasuhisa_furuichi@po.fujisawa.co.jp

While the immunosuppressant tacrolimus (FK506) is known to be neuroprotective following cerebral ischemia, the mechanisms underlying its neuroprotective properties are not fully understood. To determine the mode of action by which tacrolimus ameliorates neurodegeneration after transient focal ischemia, we therefore evaluated the effect of tacrolimus on DNA damage, release of cytochrome c, activation of microglia and infiltration of neutrophils following a 60-min occlusion of the middle cerebral artery (MCA) in rats. In this model, cortical brain damage gradually expanded until 24 h after reperfusion, whereas brain damage in the caudate putamen was fully developed within 5 h. Tacrolimus (1 mg/kg) administered immediately after MCA occlusion significantly reduced ischemic damage in the cerebral cortex, but not in the caudate putamen. Tacrolimus decreased both apoptotic and necrotic cell death at 24 h and reduced the number of cytochrome c immunoreactive cells at 8 h after reperfusion in the ischemic penumbra in the cerebral cortex. In contrast, tacrolimus did not show significant neuroprotection for necrotic cell death and reduction of cytochrome c immunoreactive cells in the caudate putamen. Tacrolimus also significantly decreased microglial activation at 8 h and inflammatory markers (cytokine-induced neutrophil chemoattractant and myeloperoxidase [MPO] activity) at 24 h after reperfusion in the ischemic cortex but not in the caudate putamen. These results collectively suggest that tacrolimus ameliorates the gradually expanded brain damage by inhibiting both apoptotic and necrotic cell death, as well as suppressing inflammatory reactions.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D002421 Caudate Nucleus Elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. Caudatus,Nucleus Caudatus,Caudatus, Nucleus,Nucleus, Caudate
D002546 Ischemic Attack, Transient Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6) Brain Stem Ischemia, Transient,Cerebral Ischemia, Transient,Crescendo Transient Ischemic Attacks,Transient Ischemic Attack,Anterior Circulation Transient Ischemic Attack,Brain Stem Transient Ischemic Attack,Brain TIA,Brainstem Ischemia, Transient,Brainstem Transient Ischemic Attack,Carotid Circulation Transient Ischemic Attack,Posterior Circulation Transient Ischemic Attack,TIA (Transient Ischemic Attack),Transient Ischemic Attack, Anterior Circulation,Transient Ischemic Attack, Brain Stem,Transient Ischemic Attack, Brainstem,Transient Ischemic Attack, Carotid Circulation,Transient Ischemic Attack, Posterior Circulation,Transient Ischemic Attack, Vertebrobasilar Circulation,Transient Ischemic Attacks, Crescendo,Vertebrobasilar Circulation Transient Ischemic Attack,Attack, Transient Ischemic,Attacks, Transient Ischemic,Brainstem Ischemias, Transient,Cerebral Ischemias, Transient,Ischemia, Transient Brainstem,Ischemia, Transient Cerebral,Ischemias, Transient Brainstem,Ischemias, Transient Cerebral,Ischemic Attacks, Transient,TIA, Brain,TIAs (Transient Ischemic Attack),Transient Brainstem Ischemia,Transient Cerebral Ischemia,Transient Cerebral Ischemias,Transient Ischemic Attacks
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017628 Microglia The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling. Microglial Cell,Cell, Microglial,Microglial Cells,Microglias

Related Publications

Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
September 2004, Brain research. Molecular brain research,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
June 2009, Journal of molecular neuroscience : MN,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
October 2001, Neurological research,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
September 2008, Brain research,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
March 2007, Neuroscience letters,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
October 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
November 2007, Pharmacology, biochemistry, and behavior,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
January 2012, Journal of neurosurgical anesthesiology,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
December 2021, Metabolic brain disease,
Yasuhisa Furuichi, and Takahisa Noto, and Ji-Yao Li, and Takuma Oku, and Masayuki Ishiye, and Akira Moriguchi, and Ichiro Aramori, and Nobuya Matsuoka, and Seitaro Mutoh, and Takehiko Yanagihara
January 2019, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!